PMC:7103696 / 5584-6613
Annnotations
LitCovid-PD-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T12 | 622-627 | Body_part | denotes | scale | http://purl.obolibrary.org/obo/UBERON_0002542 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T31 | 64-72 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T52 | 197-202 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
| T53 | 244-253 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | organized |
| T54 | 668-669 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T55 | 838-850 | http://purl.obolibrary.org/obo/OBI_0000245 | denotes | Organization |
| T56 | 857-860 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T57 | 926-929 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T58 | 949-950 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T15 | 289-294 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T16 | 305-312 | Chemical | denotes | Kaletra | http://purl.obolibrary.org/obo/CHEBI_145924 |
| T17 | 348-359 | Chemical | denotes | Chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
| T18 | 366-375 | Chemical | denotes | Darunavir | http://purl.obolibrary.org/obo/CHEBI_367163 |
| T19 | 511-516 | Chemical | denotes | drugs | http://purl.obolibrary.org/obo/CHEBI_23888 |
| T20 | 695-706 | Chemical | denotes | Chloroquine | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T48 | 0-203 | Sentence | denotes | Considering the clinical and epidemiological characteristics of COVID-19, the possible effective medications are in dire need to improve the prognosis of the patients and to stem the spread of the virus. |
| T49 | 204-434 | Sentence | denotes | More than 200 clinical trials have been organized mainly for the study of anti-viral drugs including Kaletra, Remdesivir, Arbidol, Favipiravir, Chloroquine, HCQ, Darunavir, Lianhua Qingwen Granules and Shuanghuanglian Oral Liquid. |
| T50 | 435-581 | Sentence | denotes | While the clinicians are enthusiastic about exploring the efficacy of these drugs, these trials are subject to all kinds of practical limitations. |
| T51 | 582-653 | Sentence | denotes | The majority of the trials are small in scale and repetitive in nature. |
| T52 | 654-729 | Sentence | denotes | For instance, a dozen clinical trials on Chloroquine have been carried out. |
| T53 | 730-820 | Sentence | denotes | Furthermore, due to the difference in design methodology, contradictory results may arise. |
| T54 | 821-948 | Sentence | denotes | The World Health Organization (WHO) has shown deep concern over the quality of these clinical trials and has provided guidance. |
| T55 | 949-1029 | Sentence | denotes | A multitude of domestic experts also contributed their wisdom in different ways. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 127 | 158-166 | Species | denotes | patients | Tax:9606 |
| 128 | 305-312 | Chemical | denotes | Kaletra | MESH:C558899 |
| 129 | 314-324 | Chemical | denotes | Remdesivir | MESH:C000606551 |
| 130 | 326-333 | Chemical | denotes | Arbidol | MESH:C086979 |
| 131 | 335-346 | Chemical | denotes | Favipiravir | MESH:C462182 |
| 132 | 348-359 | Chemical | denotes | Chloroquine | MESH:D002738 |
| 133 | 361-364 | Chemical | denotes | HCQ | MESH:D006886 |
| 134 | 366-375 | Chemical | denotes | Darunavir | MESH:D000069454 |
| 135 | 695-706 | Chemical | denotes | Chloroquine | MESH:D002738 |
| 136 | 64-72 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 137 | 460-472 | Disease | denotes | enthusiastic |